Thyrocare Technologies Ltd
NSE:THYROCARE

Watchlist Manager
Thyrocare Technologies Ltd Logo
Thyrocare Technologies Ltd
NSE:THYROCARE
Watchlist
Price: 914.55 INR 0.64% Market Closed
Market Cap: 48.4B INR
Have any thoughts about
Thyrocare Technologies Ltd?
Write Note

Operating Margin
Thyrocare Technologies Ltd

17.1%
Current
22%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
17.1%
=
Operating Profit
1.1B
/
Revenue
6.2B

Operating Margin Across Competitors

Country IN
Market Cap 48.4B INR
Operating Margin
17%
Country US
Market Cap 78.1B USD
Operating Margin
4%
Country US
Market Cap 74.5B EUR
Operating Margin
4%
Country US
Market Cap 57.6B USD
Operating Margin
3%
Country DE
Market Cap 25.5B EUR
Operating Margin
8%
Country DE
Market Cap 18.9B EUR
Operating Margin
7%
Country US
Market Cap 19.2B USD
Operating Margin
9%
Country US
Market Cap 17B USD
Operating Margin
14%
Country DE
Market Cap 12.8B EUR
Operating Margin
8%
Country US
Market Cap 12.6B USD
Operating Margin
15%
Country AU
Market Cap 13.2B AUD
Operating Margin
9%
No Stocks Found

Thyrocare Technologies Ltd
Glance View

Market Cap
48.4B INR
Industry
Health Care

Thyrocare Technologies Ltd. engages in provison of indepedent diagnostic and pathological laboratory services. The company is headquartered in Navi Mumbai, Maharashtra and currently employs 2,115 full-time employees. The company went IPO on 2016-05-09. The firm operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The firm offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The firm offers various kinds of tests, such as Aarogyam X, Aarogyam XL, Aarogyam 1.1, Aarogyam 1.2 and Covid Antibody GT. The company also offers Thyroxine (T4), Triiodothyronine (T3), Thyroid-stimulating hormone and Complete Vitamin Profile tests.

THYROCARE Intrinsic Value
677.88 INR
Overvaluation 26%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
17.1%
=
Operating Profit
1.1B
/
Revenue
6.2B
What is the Operating Margin of Thyrocare Technologies Ltd?

Based on Thyrocare Technologies Ltd's most recent financial statements, the company has Operating Margin of 17.1%.